阿拉伯国家抗发作药物的药物遗传学:综合性综述
1Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Future science OA
|July 16, 2025
概括
基因检测可以个性化阿拉伯人口治疗. 识别特定的基因变异有助于预测抗发作药物反应,耐药性和不良反应,改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 药物遗传学 药物遗传学
- 遗传学 是一个遗传学.
背景情况:
- 影响全球数以百万计的人,其特点是由于神经活动异常而发作.
- 虽然抗发作药物 (ASM) 治疗,但耐药性和多种反应需要个性化治疗方法.
- 遗传因素显著影响的易感性和个体对ASM的反应.
研究的目的:
- 审查影响阿拉伯人口抗发作药物 (ASM) 疗效和安全性的药物遗传学因素.
- 突出基因测试在优化治疗中的作用.
- 探索个性化医学在治疗方面的潜力.
主要方法:
- 对专注于阿拉伯人口 (沙特阿拉伯,约旦,埃及,突尼斯,伊拉克) 的药物遗传学研究的审查.
- 对包括MTHFR,MDR1,ABCB1,miR-146a,GABARG2,IL-1β,EPHX1和CYP3A422在内的基因遗传变异的分析.
- 检查这些变异如何与ASM疗效,耐药性和不良药物反应 (ADRs) 相关联.
主要成果:
- 关键基因中的遗传变异可以预测耐药性和对ASM的反应.
- 特定的遗传标记与改善药物剂量和最小化药物不良反应 (ADRs) 有关.
- 药物遗传学测试为根据个体遗传特征量身定制治疗提供了一条途径.
结论:
- 使用基因标记物的个性化治疗可以提高抗发作药物的有效性和安全性.
- 基因检测促进了更好的治疗结果,并降低了患者药物诱导并发症的风险.
- 在临床实践中实施药物遗传学可以优化阿拉伯人口中的管理.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
282
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
282
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
660
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
660
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
455
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
455
01:08Antiepileptic Drugs: Sodium Channel Blockers
905
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
905
01:24Epilepsy and Seizures: Overview
285
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
285
01:14Antiepileptic Drugs: Glutamate Antagonists
521
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
521